Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

A lung cancer researcher describes her journey toward a career in science at Novartis.

Meet a Senior Medical Director at Novartis who is part of our new “Women in Science” series